AUGMENTED INTELLIGENCE IN DRUG DISCOVERY XCHANGE
Philadelphia
March 28, 2024

Welcome to hubXchange’s Augmented Intelligence (AI) in Drug Discovery Xchange Philadelphia 2024, bringing together executives from pharma and biotech to address and find solutions to the key issues faced in AI-led drug discovery.

Discussion topics will cover Data Quality, Target Identification, Lead Generation & Lead Optimization and Drug Response Prediction.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking with your peers.

Please note this is an In-Person meeting.

VENUE DETAILS:
Doubletree by Hilton Philadelphia Airport,
4509 Island Avenue,
Philadelphia, PA, 19153, US

SNAPSHOTS OF DISCUSSION TOPICS

  • Elevating Generative AI: Nurturing data quality for precision, fairness, and innovation.
  • Generating biological insights from noisy data.
  • Role of AI in target discovery: challenges and opportunities
  • Identification of novel targets to drug for a disease of interest
  • Expanding and measuring applicability domains in machine learning
  • Use of AI/ML in lead optimization (tbc)
  • Predicting patient response using machine learning: where are we now?
  • Can machine learning methods provide insights and predictions for cancer drug response?

Full Xchange Agenda

Data Quality

Time
Titles and Bullets
Facilitator
8:00 – 8:30
Registration
8:30 – 9:00

Opening Address & Keynote Presentation

9:05 – 10:05
Generating biological insights from noisy data
  • The value of noisy data in Machine Learning
  • Single cell and Spatial transcriptomics data quality in targets & biomarkers discovery
  • Ontologies integration in clinical meta data of omics sources

Yaron was appointed as Senior Vice President and Senior Advisor, Data and Informatics Solutions in May 2023. In his role Yaron is responsible for the overall data flow inside and outside the organization. Yaron supports the Computational Discovery unit in the ongoing development of the computational platforms, and also oversees the establishment of systems for data analytics across the organization. Yaron joined Compugen in 2019 as Senior Vice President and Senior Advisor, Computational Discovery. Yaron has more than 15 years of experience in the fields of research and development informatics, data sciences and technology in the biotech and pharma space with hands-on experience using cloud-based high throughput computational, machine learning and genomics platforms for drug discovery and development applications in precision medicine. In his extensive pharma and biotech career, he has held senior R&D Informatics roles at Human Longevity, AstraZeneca, Eli Lilly, Global Gene Corp. and Affymetrix. Yaron continues to serve as Chief Information Officer and Senior Advisor at Engine Biosciences. Yaron received a B.Sc. in Biology from Tel Aviv University, a Ph.D. in Bioengineering from the University of Illinois and an MBA from the University of Chicago, Booth School of Business. He also held an Adjunct Assistant Professor position at the Centre for Quantitative Medicine of Duke-National University of Singapore, Graduate Medical School.

Yaron Turpaz
10:10 – 10:40
1-2-1 Meetings / Networking Break
10:40 – 11:10
1-2-1 Meetings / Networking Break
11:10 – 11:20
Morning Refreshments
11:20 – 12:20

Sponsor led roundtable

12:20 – 13:20

Networking Lunch

13:20 – 13:50

Spotlight Presentation

13:55 – 14:25

1-2-1 Meetings / Networking Break

14:25 – 14:55

1-2-1 Meetings / Networking Break

14:55 – 15:05

Afternoon Refreshments

15:05 – 15:35

Sponsor led poster presentation

15:40 – 16:40
Elevating generative AI: Nurturing data quality for precision, fairness, and innovation
  • How to guarantee there is model accuracy and reliability
  • Adhere to standards and best practices
  • Ensure there is no bias in models

Suku Muramula is a Solution Architect. As a passionate problem solver and technology enthusiast, he has worked in the field of IT and solution design for over two decades. In his role as a lead Solution Architect, he has collaborated with diverse teams, ranging from developers and engineers to business stakeholders. His primary focus has been on crafting innovative and effective solutions that align with the organization’s strategic goals and objectives. As a strong believer in the power of teamwork and communication, he enjoys engaging with stakeholders to understand their requirements and translate them into actionable and scalable solutions. His goal is to ensure that technology enables and enhances the business processes, delivering tangible value and fostering growth.

suku muramula
16:40 – 17:40
Evening Drinks Reception

Partners

AI in Drug Discovery Xchange | philadelphia 2024
Register